Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT04855721
What this trial is testing

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

Who this might be right for
Plaque Psoriasis
Aurigene Discovery Technologies Limited 141
Post-approval studies (Phase 4)Study completedNCT06336343
What this trial is testing

Bimekizumab in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06672393
What this trial is testing

Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 375
Testing effectiveness (Phase 2)Ended earlyNCT00162253
What this trial is testing

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis, Moderate to Severe
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT00645892
What this trial is testing

Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 32
Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Large-scale testing (Phase 3)Study completedNCT01544595
What this trial is testing

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 1,147
Large-scale testing (Phase 3)Study completedNCT01265667
What this trial is testing

Trial of CF101 to Treat Patients With Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 293
Testing effectiveness (Phase 2)Study completedNCT05096364
What this trial is testing

Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Akeso 251
Testing effectiveness (Phase 2)UnknownNCT03745417
What this trial is testing

Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 5
Early research (Phase 1)UnknownNCT03675542
What this trial is testing

The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis Vulgaris
Aarhus University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00292396
What this trial is testing

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 180
Not applicableEnded earlyNCT00795353
What this trial is testing

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 64
Testing effectiveness (Phase 2)Study completedNCT02949388
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Innovation Pharmaceuticals, Inc. 199
Testing effectiveness (Phase 2)Study completedNCT06972888
What this trial is testing

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Accro Bioscience (Suzhou) Limited 145
Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Large-scale testing (Phase 3)Study completedNCT01729754
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 1,090
Post-approval studies (Phase 4)Study completedNCT04914429
What this trial is testing

Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 327
Large-scale testing (Phase 3)Study completedNCT04607980
What this trial is testing

Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 563
Next Page